[Preoperative evaluation of hemorrhagic risk].
Evaluation of bleeding risk before surgery requires both precise knowledge of epidemiological data relating to haemostasis disorders and a true clinical approach to help guide the diagnosis. The patient's individual and familial history is recovered during both the interview with the anaesthesiologist and the clinical examination. Preoperative haemorrhage risk prevalence is 1/40,000 patients in patients with asymptomatic congenital haemostasis disorders with low bleeding and 1/2,000 patients for acquired asymptomatic haemostasis disorders. Deficits in haemostasis factors, i.e., congenital disorders with haemorrhage potential, have an overall prevalence of 1/6,500 patients. Whatever the clinical case, haemorrhage disorders will arise in patients with either congenital or acquired bleeding abnormalities without symptoms. To work in close collaboration with haemobiologists and to request appropriate biological screening tests, it is therefore important to take into account prevalence data according to the surgical environment from which the patient will benefit.